Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASC42 in primary biliary cholangitis (phase 2)
CTR20213229Phase 2Completed
- Sponsor
- Gannex Pharma Co., Ltd.
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of asc42 in primary biliary cholangitis (PBC), sponsored by Gannex Pharma Co., Ltd.. Started Dec 2021; status: completed.
02
Drugs
asc42
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on CTR20213229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213229.